Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitro

OBJECTIVES: Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease with complex pathogenic mechanisms. Complement C1q has been shown to play a major role in SLE, and autoantibodies against C1q (anti‐C1q) are strongly associated with SLE disease activity and severe lupus...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabatscher, Pascal Alexander, Trendelenburg, Marten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345742/
https://www.ncbi.nlm.nih.gov/pubmed/35928801
http://dx.doi.org/10.1002/cti2.1408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345742/
https://www.ncbi.nlm.nih.gov/pubmed/35928801
http://dx.doi.org/10.1002/cti2.1408

Ejemplares similares